All FAQs

What is the evidence supporting varenicline plus nicotine patch versus varenicline alone for smoking cessation?

Posted on Dec. 06, 2022
Last updated on Dec. 06, 2022

Read more
What continuous glucose monitoring (CGM) metrics measure glycemic control and who would benefit most from monitoring these metrics?

Posted on Dec. 06, 2022
Last updated on Dec. 06, 2022

Read more
What are the most effective non-pharmacologic behavioral interventions for smoking cessation?

Posted on Jun. 24, 2022
Last updated on Jun. 24, 2022

Opioid withdrawal syndrome encompasses the signs and symptoms that occur as a result of a rapid decrease or cessation of opioids after prol…
Read more
What are the gastrointestinal adverse effects of the glucagon-like peptide 1 receptor agonists, and how should they be managed?

Posted on Jan. 31, 2022
Last updated on Mar. 30, 2022

Gastrointestinal (GI) adverse effects are frequently reported treatment-related side effects of the glucagon-like peptide 1 receptor agonis…
Read more
Can chronic opioid use cause endocrinopathies?

Posted on Aug. 27, 2021
Last updated on Aug. 30, 2021

According to the Centers for Disease Control and Prevention (CDC), in 2019, 20.4% of adults in the United States (US) suffered from chroni…
Read more
What adverse effects are unique to sodium-glucose co-transporter 2 inhibitors?

Posted on Aug. 27, 2021
Last updated on Apr. 18, 2022

Sodium-glucose co-transporter 2 (SGLT2) is found in the proximal renal tubule and its function is to reabsorb filtered glucose from the uri…
Read more
How should withdrawal symptoms be managed when discontinuing opioids in opioid-dependent patients?

Posted on Feb. 06, 2020
Last updated on Sep. 04, 2020

Opioid withdrawal syndrome encompasses the signs and symptoms that occur as a result of a rapid decrease or cessation of opioids after prol…
Read more
What is the Illinois Naloxone Standing Order and how does a patient obtain naloxone from a pharmacy without a prescription? What naloxone dosage forms are available?

Posted on Feb. 05, 2020
Last updated on Feb. 06, 2020

Every day, more than 130 people in the United States die after overdosing on opioids.1 In response to the growing opioid crisis, Illinois h…
Read more
How does Nucynta® (tapentadol) differ from other opioids when treating chronic, non-cancer pain?

Posted on Jan. 30, 2020
Last updated on Jan. 30, 2020

In 2016, The Centers for Disease Control and Prevention (CDC) published a guideline for prescribing opioids for chronic pain in an effort t…
Read more
What treatments are available for patients with opioid use disorder (OUD)?

Posted on Jan. 27, 2020
Last updated on Feb. 10, 2020

Opioid use disorder (OUD), as defined by the American Society of Addiction Medicine (ASAM), is “a primary, chronic disease of brain reward,…
Read more
What guidance is available for tapering long-term opioid analgesics?

Posted on Jan. 23, 2020
Last updated on Jan. 24, 2020

In 2016, the Centers for Disease Control and Prevention (CDC) released a guideline comprised of 12 recommendations on prescribing opioids f…
Read more